Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Humacyte, Inc.

NASDAQ: HUMA · Life Sciences · 3 alerts · CIK 1818382

Share price
$0.5403Close, Nov 16
Market cap
$150M
Shares outstanding
277.8MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Humacyte, Inc. filings on SEC EDGAR ↗

4:32 PM ET 10-Q
Financial Results

Humacyte Q3 2026 Results: Net Loss of $15.5M, Loss Narrows

Humacyte, Inc. reported a significant increase in cash and cash equivalents to $64.5 million as of September 30, 2026, following the commercialization of Symvess. The company recorded a litigation settlement liability of $9.75 million and an accumulated deficit of $796.8 million, while common stock outstanding grew to over 277 million shares.

Key figure
Net loss $15.5M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.